Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )

Clinical trial NCT02117791 · COMPLETED

Trial details

NCT number: NCT02117791
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension, Pulmonary

Start date: 2014-07-16
Primary completion: 2023-04-03
Enrollment: 1298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.